Back

Impact of changes in proteinuria on the risk of atrial fibrillation in patients with diabetes mellitus: a nationwide population-based study

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Prediction of incident atrial fibrillation: from biomarkers to artificial intelligence Clinical ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Hee-Won Rha

Seoul National University, Seoul (Korea (Republic of))

6 More presentations in this session

Presentation thumbnail
Proteomic and genomic evaluation of plasma protein biomarkers for atrial fibrillation
Mr O. Vad (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Circulating ketone bodies, genetic predisposition, and incident atrial fibrillation
Ms Y. Sun (CN)
Abstract Slides Video
Presentation thumbnail
Polygenic risk score for prediction of atrial fibrillation according to presence of the hypertrophic cardiomyopathy
Doctor B. Joung (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Proteinuria and the risk of incident atrial fibrillation according to diabetes stage in patients with diabetes: a nationwide population-based cohort study
Mr M. Yeo (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Artificial intelligence-enabled electrocardiogram for left ventricular diastolic dysfunction and long-term risk of new-onset atrial fibrillation
Doctor G. Tsaban (Rochester, US)
Abstract Slides Video

Access the full session

Session thumbnail
Prediction of incident atrial fibrillation: from biomarkers to artificial intelligence

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Proteinuria and the risk of incident atrial fibrillation according to diabetes stage in patients with diabetes: a nationwide population-based cohort study
thumbnail
Congress Presentation
Prognostic value of proteinuria in patients with acute heart failure
thumbnail
Congress Presentation
Insights into type 2 diabetes mellitus in atrial fibrillation patients: a proteomics approach

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources